-
Growth of the pharmaceutical industry in developing economies is driving market growth
The Asia Pacific Pharmaceutical Glass Packaging market CAGR is expanding due to the growing pharmaceutical industry in developing economies. The emerging economies in the region have been witnessing an increase in pharmaceutical consumption and manufacturing owing to different factors like rising population and growing healthcare requirements, leading to an increased demand for pharmaceutical products. Moreover, the improving healthcare infrastructure, rising income levels, and surging middle-class population help in broadening the pharmaceutical sector in the Asia Pacific region. As a result, there is an increased demand for high-quality packaging solutions for ensuring the efficacy, safety, and integrity of pharmaceutical products.
Glass packaging has become a preferred option for pharmaceuticals because of its inert nature, minimizing the risk of chemical reactions between the container and contents, as it provides prime barrier features by protecting the drugs from oxygen, moisture and other external factors which can deteriorate their stability. Glass packaging is eco-friendly and recyclable which aligns with the global sustainability trend.
Furthermore, the advancements in glass manufacturing technologies have resulted in the development of new and innovative packaging designs catering to the demands of pharmaceutical industries. This improves the usability, functionality, and aesthetics of glass packaging, hence boosting market growth. Moreover, transparency is provided by the glass packaging as it allows for easy inspection of content, which is essential for making sure that the product aligns with the regulatory standards. Also, the rising preference for generic drugs and biopharmaceuticals in emerging countries is boosting the demand for high-quality packaging solutions as they require stringent storage conditions.
The increasing prevalence of chronic diseases, expanding pharmaceutical distribution networks, and growing healthcare lead to market growth. Thus driving the Pharmaceutical Glass Packaging market revenue.
SGD Pharma, which had successfully run a campaign using 20% post-consumer recycled (PCR) glass at its Zhanjiang plant in China in September of the Year 2024. The purpose of this action is to lessen carbon footprints and minimize reliance on virgin raw materials in accordance with the global sustainability initiatives of SGD Pharm. This particular initiative not only provides solutions to the environmental concerns, but it also tackles the growing demand for eco-friendly packing in the cosmetics and pharmaceutical market.
